GlaxoSmithKline's $70 Million Payout ~ OPOLAW Injury Blog

Thursday, January 29, 2009

GlaxoSmithKline's $70 Million Payout

Pharmaceutical house GlaxoSmithKline (GSK) is paying out $70 million to cancer patients after allegations the company was charging inflated prices for cancer treatment drugs. There are between one million and five million cancer patients who used drugs Kytril and Zofran since 1991, and will potentially be eligible for refunds. The settlement, which was reached in August, has to be approved by the U.S. District Court in Boston. It is part of a continuing lawsuit filed in 2001 concerning 28 drug companies accused of defrauding patients by overcharging for drugs.

No comments:

Post a Comment